N. Alkema

Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways

A. V. D. Van Der Zee, S. de Jong, G. Meersma, 2016, Genome Medicine.

Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods

A. Zee, A. V. D. Van Der Zee, S. de Jong, 2015, Scientific Reports.

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer

E. Cauberg, M. Boomsma, M. Hoogland, 2022, European urology open science.

Grand Rounds: A Patient With Autosomal Dominant Polycystic Kidney Disease With Persistent Gross Hematuria.

N. Alkema, L. Wymenga, 2017, Urology.

Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions.

S. de Jong, M. V. van Vugt, G. Wisman, 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer

M. Widschwendter, E. Schuuring, A. V. D. Van Der Zee, 2017, BMC Medicine.

Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.

H. Hollema, A. V. D. Van Der Zee, S. de Jong, 2014, Gynecologic oncology.

Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions.

S. de Jong, G. Wisman, N. Alkema, 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Novel targets and clinically relevant models for ovarian cancer

G. Wisman, N. Alkema, S. D. Jong, 2015 .